Sagimet Biosciences (SGMT) Analyst & Key Data

Analyst Consensus

Buy8 analysts

Buy

Updated Sep 12, 2026

Total Analysts8

Buy

7

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$10.88

DCF Value-90.38%

$1.05

Potential downside vs current price

Current Stock Price

$10.88

DCF Value-90.38%

$1.05

Potential downside vs current price

Analyst Consensus

Buy8 analysts

Buy

Updated Sep 12, 2026

Total Analysts8

Buy

7

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$10.88

DCF Value-90.38%

$1.05

Potential downside vs current price

Current Stock Price

$10.88

DCF Value-90.38%

$1.05

Potential downside vs current price

Sagimet Biosciences Inc.